Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00697138 · ClinicalTrials.gov registry record · Phase 1
Agonist Replacement Therapy for Cocaine Dependence
A Phase 1 study, sponsored by University of Kentucky.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT00697138 is a Phase 1 study that has completed, run by University of Kentucky. The registered enrollment target is 46 participants.
The verdict
NCT00697138, a Phase 1 study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
Cocaine dependence is a significant public health concern. The proposed research will provide important clinical information regarding the efficacy of agonists replacement therapies for managing cocaine dependence.
Interventions
- DRUG d-Amphetamine; Atomoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2006-06 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00697138
The ClinicalTrials.gov registry entry for NCT00697138 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which d-Amphetamine; Atomoxetine is the first listed.
NCT00697138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00697138 about?
NCT00697138 is a clinical study titled "Agonist Replacement Therapy for Cocaine Dependence". Cocaine dependence is a significant public health concern. The proposed research will provide important clinical information regarding the efficacy of agonists replacement therapies for managing cocaine dependence.
What is the current status of trial NCT00697138?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2006-06. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00697138?
The interventions under investigation include: d-Amphetamine; Atomoxetine (DRUG).
Who is sponsoring clinical trial NCT00697138?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.